News
Novo unveils first data for 'triple G' agonist in diabetes
Novo Nordisk has reported the first clinical data with its triple G agonist for diabetes, in China, as it starts an international trials programme.
News
AI in drug discovery and development: news watch
Recent developments in the biopharma AI world include a big financing for Verily, and updates from Zealand, Latent Labs, Insilico, and BMS/insitro.
News
Update: Rumour confirmed as MSD buys Terns for $6.7bn
MSD's glut of pipeline-boosting deals in the build-up to a looming patent cliff has continued with a $6.7bn bid to acquire Terns Pharma.
News
Karyopharm eyes Xpovio filing in myelofibrosis on mixed data
Despite hitting just one of two efficacy endpoints in a pivotal trial, Karyopharm thinks it still has a path to approval for Xpovio in myelofibrosis.
News
MSD taps Quotient for IBD drug targets in $2.2bn deal
MSD is paying $20m upfront to activate an alliance with Flagship's Quotient Therapeutics to find new targets in inflammatory bowel disease.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
